| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.3 | 4e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |